T1	Outcomes 1406 1417	median CD4%
T2	Outcomes 1506 1528	safety or tolerability
T3	Outcomes 1657 1682	permanent discontinuation
T4	Outcomes 1833 1865	NFV pharmacokinetic measurements
T5	Outcomes 2025 2041	pharmacokinetics
T6	Outcomes 2046 2050	NVP,